Education
About Us
Working with TipRanks
Follow Us
Tiziana Life Sciences Plc (TLSA)
NASDAQ:TLSA
Total Valuation
Tiziana Life Sciences has a market cap or net worth of $175.00M. The enterprise value is ―.
Market Cap$175.00M
Enterprise Value―
Share Statistics
Tiziana Life Sciences has 111,462,616 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding111,462,616
Owned by Insiders―
Owned by Institutions0.09%
Financial Efficiency
Tiziana Life Sciences’s return on equity (ROE) is -3.20 and return on invested capital (ROIC) is -319.08%.
Return on Equity (ROE)-3.20
Return on Assets (ROA)-1.45
Return on Invested Capital (ROIC)-319.08%
Return on Capital Employed (ROCE)-3.19
Revenue Per Employee0.00
Profits Per Employee-1.92M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tiziana Life Sciences is 0.00. Tiziana Life Sciences’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, Tiziana Life Sciences had revenue of 0.00 and earned -17.69M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-17.98M
Pretax Income-17.24M
Net Income-17.69M
EBITDA-17.14M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -7.70M and capital expenditures 0.00, giving a free cash flow of -7.70M billion.
Operating Cash Flow-7.70M
Free Cash Flow-7.70M
Free Cash Flow per Share-0.07
Dividends & Yields
Tiziana Life Sciences pays an annual dividend of $0.029, resulting in a dividend yield of ―
Dividend Per Share$0.029
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.47
52-Week Price Change153.23%
50-Day Moving Average1.23
200-Day Moving Average1.01
Relative Strength Index (RSI)64.58
Average Volume (3m)370.61K
Important Dates
Tiziana Life Sciences upcoming earnings date is Sep 27, 2023, TBA Not Confirmed.
Last Earnings DateMay 23, 2023
Next Earnings DateSep 27, 2023
Ex-Dividend DateJul 09, 2021
Financial Position
Tiziana Life Sciences as a current ratio of 1.12, with Debt / Equity ratio of 4.46%
Current Ratio1.12
Quick Ratio1.12
Debt to Market Cap0.00
Net Debt to EBITDA0.05
Interest Coverage Ratio-1.80K
Taxes
In the past 12 months, Tiziana Life Sciences has paid 449.00K in taxes.
Income Tax449.00K
Effective Tax Rate-0.03
Enterprise Valuation
Tiziana Life Sciences EV to EBITDA ratio is 0.05, with an EV/FCF ratio of 0.06.
EV to Sales0.00
EV to EBITDA0.05
EV to Free Cash Flow0.06
EV to Operating Cash Flow0.06
Balance Sheet
Tiziana Life Sciences has $18.12M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$18.00M billion.
Cash & Marketable Securities$18.12M
Total Debt$0.00
Net Cash-$18.00M
Net Cash Per Share-$0.16
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tiziana Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―